This company has shut down. Visiox is no longer operating — its last tracked round was a Seed in 2022.
Explore the Startup GraveyardVisiox biopharmaceutical company focused on the development and commercialization to address highly prevalent diseases.
Visiox has raised $7.0M in total funding. The most recent round was Seed. The last funding was announced in August 2022.
Visiox is headquartered in Tarrytown, United States.
Visiox biopharmaceutical company focused on the development and commercialization to address highly prevalent diseases.
Visiox is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Visiox — Funding & Investors." VCBacked, August 3, 2022, https://www.vcbacked.co/company/visiox. Accessed August 15, 2026.
VCBacked. (2022). Visiox — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/visiox
{{cite web |title=Visiox — Funding & Investors |url=https://www.vcbacked.co/company/visiox |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated